Skip to main content
Caplight Logo









Ingenious Targeting Laboratory

Ingenious Targeting Laboratory

Private
Ronkonkoma, New YorkHealthcare & Life Scienceshttps://www.genetargeting.com/

Last Round

Grant

Jun 9, 2022

Total Funding Raised

$1.36M

Company Overview

Ingenious Targeting Laboratory is a biotechnology company that provides custom genetically engineered mouse, rat, and rabbit models for biomedical research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

genetically modified mouse modelscustom animal modelsCRISPRlab animal servicescontract research organizationCROknockout modelshumanized mouse modelstransgenic servicespreclinical researchgene targetingknockin modelsbiotech servicesphenotyping servicescolony managementcryopreservationgenotyping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ingenious Targeting Laboratory Comparables

Compare Ingenious Targeting Laboratory with similar companies based on industry and business-model similarity.

Ingenious Targeting Laboratory comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ozgene
91%
Mirimus Inc.
89%
Genoway
87%

Ingenious Targeting Laboratory Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 9, 2022
GrantJan 4, 2021
DebtMay 1, 2020
GrantFeb 11, 2019

Key People

Founding team and executive leadership

Wei Weng

CSO and CEO

Executive Team

Ingenious Targeting Laboratory Investors

Notable investors and investment history

Ingenious Targeting Laboratory investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant
NIH RADxGrant
Long Island High Technology IncubatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 40% MoM.

  • Jan 21, 2026

    Monthly visitors increased 55% MoM, reaching 3.5K.

Ingenious Targeting Laboratory Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ingenious Targeting Laboratory Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ingenious Targeting Laboratory's valuation, stock price, and market status.

Firmographic Details

HeadquartersRonkonkoma, New York
Employee Range24
Year Founded1998
Last FundingJun 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?